SC
VRTX icon

SouthState Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

SouthState Corp’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4K Sell
45
-2
-4% -$886 ﹤0.01% 600
2026
Q1 		$21K Sell
47
-15
-24% -$6.99K ﹤0.01% 560
2025
Q4 		$28.1K Buy
62
+15
+32% +$6.46K ﹤0.01% 531
2025
Q3 		$18.4K Sell
47
-31
-40% -$13K ﹤0.01% 582
2025
Q2 		$34.7K Sell
78
-50
-39% -$23K ﹤0.01% 553
2025
Q1 		$62.1K Buy
128
+111
+653% +$51.7K ﹤0.01% 493
2024
Q4 		$6.85K Buy
17
+8
+89% +$3.71K ﹤0.01% 531
2024
Q3 		$4.19K Hold
9
– – ﹤0.01% 537
2024
Q2 		$4.22K Buy
9
+7
+350% +$3.04K ﹤0.01% 546
2024
Q1 		$836 Buy
+2
New +$845 ﹤0.01% 655

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SouthState Corp's VRTX Position: Q2 2026 in Review

SouthState Corp reduced its Vertex Pharmaceuticals (VRTX) stake by 4.3% in Q2 2026, selling an estimated $886 and leaving 45 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #600.

SouthState Corp first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $62.1K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • SouthState Corp held 45 shares of Vertex Pharmaceuticals worth $22.4K as of Q2 2026.
  • SouthState Corp sold 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $886.
  • Vertex Pharmaceuticals made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #600 holding.
  • SouthState Corp first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • SouthState Corp's Vertex Pharmaceuticals position peaked at $62.1K in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.